These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 30577741

  • 1. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
    Tran N, Abhyankar V, Nguyen K, Weidanz J, Gao J.
    BMC Bioinformatics; 2018 Dec 21; 19(Suppl 20):504. PubMed ID: 30577741
    [Abstract] [Full Text] [Related]

  • 2. Improved microRNA biomarkers for pathological stages in lung adenocarcinoma via clustering of dysregulated microRNA-target associations.
    Nhat Tran, Alipourfard B, Abhyankar V, Nguyen K, Weidanz J, Gao J.
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul 21; 2017():2708-2711. PubMed ID: 29060458
    [Abstract] [Full Text] [Related]

  • 3. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
    Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J, Chen L.
    J Thorac Cardiovasc Surg; 2015 May 21; 149(5):1404-14.e4. PubMed ID: 25813410
    [Abstract] [Full Text] [Related]

  • 4. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH.
    Am J Respir Crit Care Med; 2012 Dec 01; 186(11):1160-7. PubMed ID: 23043084
    [Abstract] [Full Text] [Related]

  • 5. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
    Yang Z, Yin H, Shi L, Qian X.
    Int J Mol Med; 2020 May 01; 45(5):1397-1408. PubMed ID: 32323746
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY, Huang JC, Tang RX, Chen WJ, Chen P, Cen WL, Shi K, Gao L, Gao X, Liu AG, Peng XT, Chen G, Huang SN, Fang YY, Gu YY.
    World J Surg Oncol; 2018 Feb 02; 16(1):22. PubMed ID: 29394946
    [Abstract] [Full Text] [Related]

  • 7. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
    Patnaik S, Mallick R, Kannisto E, Sharma R, Bshara W, Yendamuri S, Dhillon SS.
    J Thorac Oncol; 2015 Mar 02; 10(3):446-53. PubMed ID: 25695220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y, Li Y, Wu Q, Deng Y.
    Oncotarget; 2016 Feb 23; 7(8):8441-54. PubMed ID: 26870998
    [Abstract] [Full Text] [Related]

  • 10. Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.
    Shao T, Wu A, Chen J, Chen H, Lu J, Bai J, Li Y, Xu J, Li X.
    Mol Biosyst; 2015 Nov 23; 11(11):3048-58. PubMed ID: 26325208
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
    Zhang X, Li P, Rong M, He R, Hou X, Xie Y, Chen G.
    Tohoku J Exp Med; 2015 Mar 23; 235(3):161-9. PubMed ID: 25746592
    [Abstract] [Full Text] [Related]

  • 12. MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer.
    Chen W, Li X.
    Technol Cancer Res Treat; 2020 Mar 23; 19():1533033820922558. PubMed ID: 32588752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 23; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 15. Construction of a transcription factor‑long non‑coding RNA‑microRNA network for the identification of key regulators in lung adenocarcinoma and lung squamous cell carcinoma.
    Zhao S, Chen H, Ding B, Li J, Lv F, Han K, Zhou D, Yu B, Yu Y, Zhang W.
    Mol Med Rep; 2019 Feb 23; 19(2):1101-1109. PubMed ID: 30569133
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification and characterization of miR-96, a potential biomarker of NSCLC, through bioinformatic analysis.
    Cai T, Long J, Wang H, Liu W, Zhang Y.
    Oncol Rep; 2017 Aug 23; 38(2):1213-1223. PubMed ID: 28656287
    [Abstract] [Full Text] [Related]

  • 19. In silico comparative genomic analysis of two non-small cell lung cancer subtypes and their potentials for cancer classification.
    Li J, Li D, Wei X, Su Y.
    Cancer Genomics Proteomics; 2014 Aug 23; 11(6):303-10. PubMed ID: 25422361
    [Abstract] [Full Text] [Related]

  • 20. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y, Chen F, Shen L, Tang X, Du C, Sun Z, Ding H, Chen J, Shen B.
    J Transl Med; 2018 May 21; 16(1):134. PubMed ID: 29784056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.